Bionic Pancreas in CFRD

Status Not yet recruiting

Clinical Trial Summary

This multi-center randomized controlled trial (RCT) will compare efficacy and safety endpoints using the insulin-only configuration of the iLet Bionic Pancreas System (BP) versus a control group using their usual care insulin delivery method and continuous glucose monitoring (CGM) during a 13-week study period in individuals ≥14 years old with cystic fibrosis-related diabetes (CFRD). After 13 weeks, participants will continue in a 13-week Extension Phase in which the BP group will continue to use the BP system and the Usual Care group will initiate use of the BP system.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06449677
Study type	Interventional
Source	Jaeb Center for Health Research
Contact	Colleen Bauza, PhD, MPH
Phone	813-975-8690
Email	cbauza@jaeb.org
Status	Not yet recruiting
Phase	Phase 3
Start date	June 2024
Completion date	March 2026

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02723968` - Cystic Fibrosis Related Diabetes Screening.	N/A
Completed	`NCT04503408` - A Comparison of Clinical Parameters in With and Without Abnormal Glucose Tolerance.
Recruiting	`NCT05723445` - The Effects of a Low Glycemic Load Diet on Dysglycemia and Body Composition in Adults With Cystic Fibrosis-Related Diabetes	N/A
Completed	`NCT04519853` - A Pilot Study of a Low Glycemic Load Diet in Adults With Cystic Fibrosis	N/A
Terminated	`NCT03234387` - A CFit Study - Baseline
Completed	`NCT03227094` - Simplification of CF-related Diabetes Screening at Home	N/A
Completed	`NCT03961516` - Glycemic Characterization and Pancreatic Imaging Correlates in Cystic Fibrosis
Terminated	`NCT03237767` - A CFit Study - Acute Exercise	N/A
Withdrawn	`NCT05229640` - Relationship Between the Development of Impaired Glucose Tolerance, the Phenotype of CFLD, and the Risk of Liver Fibrosis	N/A
Active, not recruiting	`NCT04533646` - Comparison of Meal-Time Dosing of Insulin in Cystic Fibrosis Related Diabetes	Phase 4
Recruiting	`NCT05766774` - FEED-Cystic Fibrosis (FEED-CF)	N/A
Terminated	`NCT03939065` - Sensor Augmented Pump (SAP) Therapy for Inpatient CFRD Management	N/A
Completed	`NCT02810691` - The Effect of Soluble Fiber to Reduce Post-prandial Glycemic Excursion in Adults With Cystic Fibrosis	N/A
Recruiting	`NCT05568134` - Alternate Measures of Glucose During OGTT Testing for CFRD
Recruiting	`NCT05463289` - ACCESS 2: AI for pediatriC diabetiC Eye examS Study 2	N/A
Not yet recruiting	`NCT04379726` - β-cell Function and Insulin Sensitivity in Patients With Cystic Fibrosis
Completed	`NCT03650712` - EnVision CF Multicenter Study of Glucose Tolerance in Cystic Fibrosis	N/A
Active, not recruiting	`NCT06084468` - Cardiac Structure and Function in Patients With Cystic Fibrosis
Recruiting	`NCT04530383` - Effects of Metformin on Airway Ion Channel Dysfunction in Cystic Fibrosis-related Diabetes	Phase 2
Recruiting	`NCT06149793` - SGLT2 Inhibitor Therapy in Cystic Fibrosis-related Diabetes	Phase 2/Phase 3